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ABSTRACT
Introduction: The purpose was to systematically review the literature regarding interventions to improve daily activity in individuals with chronic obstructive pulmonary disease (COPD) and chronic
heart failure (CHF). Methods: Articles found by
searching CINAHL Plus Full-Text, PubMed, and
PsycINFO databases were included in the review if
the study examined the effect of exercise- and/or psychosocial-based interventions on daily activity in individuals with COPD or CHF. Article selection, data
extraction, and evaluation of methodological rigor
and quality were performed by two independent reviewers. Nine articles for COPD and seven articles for
CHF met the inclusion criteria and were used in this
review. Results: Only four of nine studies in COPD
and two of seven studies in CHF resulted in improvement in daily activity, and of those, all but one study
included a psychosocial-based intervention. Improvements in daily activity did not occur concurrently
with changes in other outcomes such as exercise performance, quality of life, functional status, or anxiety/depression in COPD or CHF. Conclusions: Exercise-based interventions serve a limited, if any, role in
improving daily activity in individuals with COPD
and CHF. Disrupting the cycle of inactivity and deconditioning requires more than just addressing the
deconditioning aspect of this cycle. Psychosocial-based interventions are a promising, but under-investigated, intervention.
Keywords: Heart Failure; Chronic Obstructive
Pulmonary Disease; Daily Activity

1. INTRODUCTION
Daily activity is associated with a variety of health out*
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comes in patients with chronic obstructive pulmonary
disease (COPD) and chronic heart failure (CHF), including life expectancy and mortality [1-7]. However,
rehabilitative interventions for improving daily activity
have not been well-studied. Very low levels of physical
activity measured by activity questionnaires are associated with hospitalization due to exacerbation [2,3] and
mortality in patients with COPD [2]. Objective measurement of daily activity with accelerometry in patients
with COPD reaffirmed this finding; daily activity was an
independent prognostic factor for mortality and hospitalization [4]. Similarly, in patients with CHF, low daily
activity as measured by accelerometry is associated with
lower survival and mortality [5-7]. It is therefore important to understand which interventions are effective for
improving daily activity.
Although COPD and CHF have very distinct pathophysiologic mechanisms, both result in exercise intolerance and similar physically-limiting symptoms such as
breathlessness and fatigue that lead to activity avoidance
and a subsequent cycle of inactivity and deconditioning
[8-12].
Chronic obstructive pulmonary disease is characterized by progressive airflow obstruction caused by a loss
of elastic recoil and airway narrowing that is not fully
reversible in response to bronchodilators [13]. Many
individuals with COPD are inactive in daily life, most
likely as a strategy to minimize dyspnea [14]. The mechanisms for dyspnea and exercise intolerance are multifactorial and include increased resistance to airflow (especially during expiration) [15], impaired gas exchange
resulting in hypoxemia and hypercapnia [15], dynamic
hyperinflation [16], inspiratory muscle weakness, and
skeletal muscle dysfunction [17].
Chronic heart failure is a syndrome of cardiac dysfunction characterized by insufficient cardiac output [15],
resulting in limited exercise performance, abnormal ventilatory response, impaired ventilatory muscle strength,
and low perfusion of skeletal muscles with subsequent
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skeletal muscle dysfunction [8]. The symptoms that result from these various mechanisms of exercise intolerance lead to activity restriction and further functional
deterioration [9].
Although the exertional symptoms associated with
limited exercise tolerance may appear to account for inactivity in individuals with COPD and CHF, psychosocial factors such as depression and self-efficacy have also
been demonstrated to be significant determinants of participation in daily activities [18,19]. On average, individuals with chronic diseases are 1.5 - 2.0 times more
likely to be depressed [20]. Prevalence of major depresssion in individuals with COPD and CHF have been reported to be as high as 42% and 20%, respectively
[21,22]. Although decreased activity is most pronounced
in older patients with significant depression, individuals
with less severe depression are also at risk for decline in
daily activity [23]. The Longitudinal Aging Study Amsterdam found that respondents with emerging depresssion were more likely to transition to a sedentary lifestyle
[24].
Self-efficacy, defined as an individual’s beliefs about
his or her ability to exercise control over events that affect his or her life [25], is another potentially significant
determinant of daily activity. Oka et al. [26] found that
self-efficacy is a stronger predictor of daily physical activity in individuals with CHF than physical fitness
measures or RPE. In individuals with COPD, Arnold et
al. [27] found greater self-efficacy in those reporting
better physical functioning. Specifically with regard to
walking, lower walking self-efficacy as measured by the
Self-Efficacy Questionnaire-Walking is associated with a
decrease in physical activity in individuals with CHF
[28], and self-efficacy is associated with objective physical performance measures such as the six-minute walk
test (6MWT) in individuals with COPD [29].
Rehabilitative interventions for improving daily activity have not been well-studied. Ng et al. [30] systematiccally reviewed the effect of exercise training on daily
activity in individuals with COPD. They found a small
effect of exercise training on daily activity based on two
randomized trials and five cohort studies. Unfortunately,
their review only examined exercise interventions and
did not account for other confounding determinants of
daily activity. No prior systematic reviews have been
conducted to examine interventions for improving daily
activity of individuals with CHF, but three studies have
failed to demonstrate improvement in daily activity despite improvements in exercise tolerance following exercise training [31-33]. Given that exercise-based intervenetions may not result in substantial changes in daily
activity, other interventions that address impairments in
psychosocial domains may be more appropriate for improving daily activity [34]. No prior systematic review
Copyright © 2013 SciRes.

has addressed non-exercise based interventions for low
daily activity in individuals with COPD or CHF.
In summary, COPD and CHF result in a cycle of inactivity and deconditioning due to the symptoms of fatigue
and breathlessness associated with exercise intolerance.
As daily activity decreases, the risk of adverse health
outcomes increases. Furthermore, psychosocial factors
may substantially confound this cycle of inactivity and
deconditioning such that interventions for improving
daily activity may need to account for these additional
factors, especially given that exercise-based intervenetions may have a minimal effect. Therefore, the purpose
of the present systematic review is to consider and examine a broader range of interventions that are used to
improve daily activity in individuals with COPD and
CHF.

2. METHODS
2.1. Literature Search
The literature search was conducted by searching within
the article text using CINAHL Plus Full-Text (Ebsco),
PubMed, and PscyINFO databases on July 31, 2012. The
topics of “heart failure” and “COPD” were each searched
individually in conjunction with the following keywords:
“daily activity”, “daily activities”, “physical activity”,
“physical activities”, and “energy expenditure”.

2.2. Study Selection Criteria
Studies were included if physical- or psychosocial-based
interventions were used and if a change in daily activity
was assessed after the intervention period had concluded.
Only peer-reviewed studies were included in the review
and no limitations were imposed regarding year of publication. Studies were excluded if no full text was available or if the article was not published in the English
language. To limit selection bias, two authors (BK and
BS) independently searched databases and individually
selected studies based on inclusion and exclusion criteria.
Differences in study selection were discussed with a third
author and fourth author (MS and PS), and a consensus
was reached by the authors if opinions varied.

2.3. Level of Evidence
Strength of evidence for each study was appraised using
levels of evidence as described by Strauss et al. [35]. The
levels of evidence are ranked 1 to 5, with 1 being the
highest level of evidence. Each study was independently
assessed by the authors (BK and BS). If level of evidence
ratings varied by author, differences were discussed with
a third author and fourth author (MS and PS) and a consensus was reached. Articles rated 1b (randomized trial),
2b (cohort study), 3b (individual case control study) and
OPEN ACCESS
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4 (low quality case control study) were included in this
review.
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3.1.2. Levels of Evidence
All seven studies [37-43] were Level 1b based on being
randomized in design and having a methodological rigor
score greater than or equal to 60%.

2.4. Methodological Rigor
The methodological quality of studies included was assessed using the Medlicott and Harris [36] scale for
methodological rigor. Methodological rigor was rated as
follows: “Strong” 71% to 100%, “Moderate” 60% to
70%, and “Weak” 59% or less. Percentages were calculated by dividing the amount of criterion “met” by the
total amount of criterion possible that could be “met” for
that particular article. Randomized controlled trials with
“weak” methodological rigor were given a level of evidence designation “2b.” Methodological rigor was independently assessed by the authors (BK and BS). Differences in study selection were discussed with a third author and fourth author (MS and PS) and a consensus was
reached by the authors if opinions varied.

3.1.3. Methodological Rigor
Methodological rigor scores ranged from 70% to 90%
and are summarized in Table 1. Five articles [38,40-43]
were rated as “strong” (“yes” percentage from 75 - 100),
two [37,39] were judged to be “moderate” (“yes” percentage from 50 - 74), and none were determined to be
“weak” (“yes” percentage from 0 - 49). The most notable
deficiencies in rigor were related to randomization,
blinding, and long term follow-up.

3. RESULTS
3.1. Heart Failure
3.1.1. Literature Search
Three hundred and sixteen unique articles were found
using the search strategy previously outlined. The most
frequent reasons for exclusion were heterogeneous
populations, no measure of daily activity, or a lack of a
physical or psychosocial intervention. Ultimately, seven
studies [37-43] met the inclusion criteria for this review.
The results of the search strategy are outlined in Figure
1. Included studies were then analyzed for their methods,
outcome measures, level of evidence, and methodological rigor. Tables 1 and 2 summarize the methodological
rigor and extracted data of the included studies.

Figure 1. Search results for chronic heart failure.

Author

Randomized

Inclusion/Exclusion
Criteria

Group Similarity
at Baseline

Replicable

Reliable

Valid

Blinding

Dropouts Reported

Long-Term Results

Adherence

Score as Percentage

Level of Evidence

Table 1. Methodological rigor of included studies in individuals with chronic heart failure.

Gottlieb et al. 1990

Y

Y

Y

Y

Y

Y

N

Y

N

Y

80%

1b

Willenheimer et al. 2001

Y

Y

Y

Y

N

N

Y

Y

Y

Y

80%

1b

Van den Berg-Emons et al. 2004

Y

Y

Y

Y

Y

Y

Y

N

N

Y

80%

1b

Brodie et al. 2005

Y

Y

Y

Y

Y

Y

N

Y

N

N

70%

1b

Witham et al. 2005

Y

Y

Y

Y

Y

Y

Y

Y

N

Y

90%

1b

Mueller et al. 2007

Y

N

Y

Y

Y

Y

N

Y

Y

N

70%

2b

Witham et al. 2012

Y

Y

Y

Y

Y

Y

Y

Y

N

Y

90%

1b

Y = yes; N = no.
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Table 2. Extracted data for studies in individuals with chronic heart failure.
Study, Level
of Evidence,
and Rigor
Gottlieb et al.
1999
RCT
Level 1b

OUTCOMES
Subjects

Interventions
Measure of Daily activity

Treatment:
N:11
M/F: 11/0
Ages: 67(7)
LVEF(%): 22(8)
NYHC:
II: 5
III:6

M&HR 80%
Control:
N:14
M/F: 11/3
Ages: 64(10)
LVEF(%): 25(10) NYHC:
II: 4
III: 10

Visits
3x/week for 6 months
Intensity
Increased per patient
tolerance using Borg
Scale 12 to 13
Type:
UE/LE ergometer and
treadmill walking.
Progressed to 15 min on
bike and 30 min on
treadmill

Hip accelerometer (kcal/d)
Treatment + Crossover
No  286(149)361(224)
Control
No  reported
Doubly labeled water (kcal/d)
Treatment + Crossover
No  386(357) 273(133)
Control
No  reported

2001
RCT
Level 1b
M&HR 80%

Van den
Berg-Emons
et al.
2004
RCT

Treatment
N:17
Age: 64(5)
M/F: 12/5
LVEF: 35(12)
NYHC: 2.1(.7)
Control
N:20
Age: 64(8)
M/F: 14/6
LVEF: 38(10)
NYHC: 2.4(0.7)

Treatment
N:18
Age: 58.6(12.1)
M/F: 12/6
LVEF(%):24(9)
NYHC:
II: 10
III: 8

Level 1b
M&HR 80%

Control
N:16
Age: 58.6 (10.6)
M/F: 13/3
LVEF(%): 27.6(6.0)
NYHA class
II: 10
III: 6

Copyright © 2013 SciRes.

Peak VO2 (mL/kg/min)
Treatment + Crossover
 15(3)17(3)*ǂ
Control
No 
Functional Status:
Functional Status Assessment,
SF-36
No  in either group

Control Group
Usual care unspecified

Crossover:
N:5
No characteristics
reported for
cross-over group

Willenheimer
et al.

Other
Exercise Performance:
6MWT (m)
Treatment
395(49)  by 50(59)*ǂ
Control
No  410(39)  by 19(41)

Quality of Life:
MLHFQ
No  in either group

Visits
15 minutes, 2x/wk for
first 6 weeks, followed
by 45 minutes sessions
3x/wk for 11 weeks
(total of 17 weeks),
follow-up at 10 months

Habitual Physical Activity
Journal (units)
Training Group:
No  70(97)60(85)48(41)
Control Group:
No  71(68)42(55)32(41)

Quality of Life:
Patient Global Assessment of
Change in Quality of Life
Training Group:
 0(0)1.3(1.3)0.7(0.9)*ǂ
Control Group:
No  0(0)0.4(1.4)0.0(1.0)

Intensity
HR corresponding to
80% VO2 max
Type:
Cycle ergometer
interval training for 90
seconds followed by 30
second rest
Control Group
Unspecified
Visits
1 hour, 2x/wk for 3 mos
Intensity
Target HR 60% of HR
Reserve
Type
Cycle ergometer, walking,
and games in addition
to standard care
Control Group
Standard medical care

Anxiety/Depression:
CES-D
No  in either group
Exercise Performance:
Peak VO2 (mL/kg/min)
Treatment
No  16.2(3.2)17.3(4.4)
Control
No  16.1(3.3)16.6(3.6)

Four uni-axial accelerometers
No statistically significant changes
were noted when comparing:
duration of dynamic activities,
body motility, motility during
walking, # of transitions, walking
periods >10s, walking periods >5s

Exercise Performance:
6MWT (m)
Treatment
↑ 455(71)501(96)*
Control
↑ 435(77)448(84)*
Peak VO2 (mL/kg/min)
Treatment
↑ 16.6(4.2)17.8(4.0)*
Control
No  16.1(3.8)15.8(2.9)
Extensor Peak Torque (Nm/kg)
Treatment
↑ 0.78(0.29)0.88(0.32)*
Control
No  0.74(0.20)0.73(0.21)
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Continued
Brodie et al.
2005
RCT

Treatment Alone
N:22
M/F: NR
Ages: 78(6.1)
LVEF(%): 31.0(8.5)
NYHC: NR

Level 1b
M&HR 70%

Witham et al.
2005
RCT
Level 1b
M&HR 90%

Standard Care
N:18
M/F: NR
Ages: 76(6.4)
LVEF(%): 27.7(5.8)
NYHC: NR
Combined
Treatment/Standard
Care
N:20
M/F: NR
Ages: 79(6.9)
LVEF(%): 31.3(5.9)
NYHC: NR
Treatment
N:41
Age: 80(6)
M/F: 26/15
NYHC:
II: 25
III: 16
LVSD:
mild: 14
moderate: 12
severe: 15
Control
N = 41
Age:81(4)
M:F = 19:22
NYHC:
II: 21
III: 20
LVSD:
mild: 15
moderate: 13
severe: 13

Mueller et al.
2007
Level 2b

Treatment
N:25
Age: NR
M/F: 25/0
LVEF(%): < 40
NYHC: NR

M&HR 70%
Control
N:25
Age: NR
M/F: 25/0
LVEF: <40
NYHC: NR

Visits
8, 1-hr sessions over 5
months
Type
Treatment: Motivational
interviewing technique
to decrease ambivalence
to physical activity
Standard Care: Advised
in structured exercise
program including
information on local
options/opportunities.

Leisure-time physical activity
questionnaire and a 3-day
physical activity diary
Treatment Alone
Energy Expenditure
(kcal/kg/day):
↑ 6.6(2.6)9(3.3)*ǂ

Exercise Performance:
6MWT (m)
Treatment Alone
↑ 97.2(85.4)119.3(95.7)*

Standard Care
Energy Expenditure
(kcal/kg/day):
No  9.7(4.5)9.6(4.3)

Combined Treatment/Standard
Care
↑ 89.5(73.4)109.5(71.4)*

Combined Treatment/Standard
Care
Energy Expenditure
(kcal/kg/day):
↑ 8.3(2.5)10.5(4.4)*ǂ

Visits
30 minutes, 2x/week for
3 months, followed by
2 - 3x/week at home for
3 months

Triaxial accelerometer
Treatment
92,565(51,227)106,021(98,315)
109,150(70,385)*ǂ

Intensity
Borg Scale 11 - 13

Control Group
No  95,163(62,190)
93,373(62,862)82,463(53,832)

Type
Gentle seated exercise
for first 3 months, then
home exercise with
assist of video/cassette
for 3 months. Activity
diary and weekly
physiotherapist phone
calls for encouragement
and walking activity
goal-setting were
included

Exercise Performance:
6MWT (m)
Treatment
No  261(117)254(107)
262(110)
Control
No  240(93)228(102)
246(111)
Functional Status:
Functional Limitations Profile
No  in either group

Quality of Life:
Chronic Heart Failure
Questionnaire
No  in either group
Anxiety/Depression:
Hospital Anxiety Depression

Control Group
Standard medical care

Visits
30 minutes 5x/wk, with
additional 45 minutes,
2x/week for 1 month,
6.2 year follow-up

Questionnaire Modeled after
Harvard Alumni Study
(kcal/week)
Treatment
No  2137(2021)→2704(1970)

Intensity
60% - 80% of max HR
or Borg Scale 12 - 14

Control
No  1269(1162)→2085(1522)

Type
30 minutes cycling,
45 minutes walking

Standard Care
↑ 157(100)181(116.2)*

Score
No  in either group
Exercise Performance:
Peak VO2 (mL/kg/min)
Treatment
No  22.0(3.4)26.7(4.3)*→ 23.6(5.8)
*
significant immediate post
training difference only
Control
No  19.9(2.7)20.0(2.9)→
20.3(4.5)

(Activity only recorded at 6.2 year
follow-up)

Control Group:
Standard medical care

Copyright © 2013 SciRes.
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Continued
Witham et al.
2012
Level 1b
MH&R 90%

Treatment
N:53
Age: 80(6)
M/F: 35/8
NYHC:
II: 37
III: 16
LVSD:
mild: 28
moderate: 13
severe: 9
Control
N=54
Age:80(5)
M:F=37:14
NYHC:
II: 48
III: 6
LVSD:
mild: 22
moderate: 17
severe: 14

Visits
60 minutes, 2x/week for
8 weeks, followed by 16
weeks of home exercise
Intensity
Based on dyspnea
Type
Gentle seated exercise
for first 3 months, then
home exercise with
assist of video/cassette
for 3 months.
Group-based, guided
discussions regarding
exercise, support calls
by physiotherapist every
2 weeks for 8 weeks,
then monthly support
calls for 16 weeks.
Control Group
Standard medical care

Triaxial accelerometer
No difference in change between
groups at 8 or 16 weeks

Exercise Performance:
6MWT (m)
No difference in change between
groups at 8 or 16 weeks
Quadriceps Strength
No difference in change between
groups at 8 or 16 weeks
Functional Status:
Functional Limitations Profile
No difference in change between
groups at 8 or 16 weeks

Quality of Life:
Chronic Heart Failure
Questionnaire
No difference in change between
groups at 8 or 16 weeks
EuroQoL
No difference in change between
groups at 8 or 16 weeks

Anxiety/Depression:
Hospital Anxiety Depression
Score
No difference in change between
groups at 8 or 16 weeks
*

Statistically significant within-group difference; ǂStatistically significant between-group difference compared to control; values represent mean (standard deviation); MH&R = Medlicott & Harris rating of methodological rigor; LVEF = left ventricular ejection fraction; NYHC = New York Heart Association Classification; NR = not reported; UE = upper extremity; LE = lower extremity; 6MWT = 6 Minute Walk Test; VO2 = peak oxygen consumption; CES-D = Center for
Epidemiologic Studies Depression Questionnaire; LVSD = left ventricular systolic dysfunction.

3.1.4. Follow-Up
Only two studies [39,41] measured long-term results (6month or greater follow-up). The majority [37,38,40,
42,43] of studies had no follow-up after intervention
concluded.
3.1.5. Intervention Type and Dosage
Five studies [38-43] used exercise interventions, one
study [37] used psychosocial intervention, and two studies [42,43] used an exercise intervention with a psychosocial component. The average length of intervention
was 3.33 months, with a range of 1 month [39] to 6
months [38,43]. Frequency of intervention ranged from
two times per week [40] to seven times per week [39],
with the other four studies at 2 - 3 times per week.
3.1.6. Daily Activity Measures and Outcomes
Several different daily activity measures were utilized.
Four [38,40,42,43] of the seven studies used accelerometry, while the other three [37,39,41] used either a questionnaire or an activity diary. One study [38] used doubly-labeled water in conjunction with accelerometry.
Only two studies [37,42] showed between-group improvements in daily activity. The remaining five studies
Copyright © 2013 SciRes.

[38-41,43] demonstrated no improvements in daily activity.
3.1.7. Exercise Performance Measures and Outcomes
Measurements included the 6MWT [37,38,40,42,43],
peak VO2 [38,40,41], heart rate [39], and various muscular performance tests. Two studies [38,40] demonstrated improvements across multiple measures of exercise performance. The most commonly used measures
were peak VO2 [38,40,41] and the 6MWT [37,38,40,
42,43]. Significant between-group changes in 6MWT
[38], peak VO2 [38,40], exercise duration [38], and peak
torque [40] were found in two of seven studies.
3.1.8. Quality of Life Measures and Outcomes
Five studies [38,40-43] measured quality of life (QOL).
Measures included: Minnesota Living with Heart Failure
Questionnaire [38], Medical Outcomes Study-SF 36 [38],
Philadelphia Geriatric Morale Score [42], Chronic Heart
Failure Questionnaire [42,43], Patient Global Assessment
of Change in Quality of Life [41], and EuroQoL [43].
Significant between-group differences as a result of the
intervention were only found in one study using the Patient Global Assessment of Change in Quality of Life [41].

OPEN ACCESS
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3.1.9. Anxiety/Depression Measures and Outcomes
Three studies [38,42,43] measured anxiety/depression
outcomes. Depression/anxiety measures included the
Center for Epidemiologic Studies Depression Questionnaire [38] and the Hospital Anxiety and Depression Scale
[42,43]. No changes in anxiety/depression were found.
3.1.10. Functional Status Measures and Outcomes
Three studies measured functional status [38,42,43].
Measures included the Function Status Assessment [38]
and the modified Functional Limitations Profile [42,43].
No study reported significant between-group differences
in any of the aforementioned measures.
3.1.11. Concurrent Changes between Daily Activity
and Secondary Outcomes
Figure 2 summarizes the relationship between changes
in daily activity concurrent with changes in other seconddary outcome measures by plotting the within-group effect sizes of the intervention groups for all measures
across all seven studies. Overall, a positive linear relationship did not exist, with the greatest changes in daily
activity not occurring concurrently with changes in other
measures. Furthermore, only one study [37] demonstrated a within-group effect size greater than 0.50 for
daily activity.
When assessing concurrent changes in daily activity
and anxiety/depression, there were no consistent results;
two studies [38,43] showed no changes in daily activity
or anxiety/depression, another study [42] demonstrated
an increase in daily activity without a concurrent improvement in anxiety/depression, while yet another study
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[40] showed improvement in anxiety/depression without
an improvement in daily activity. No studies found concurrent change in daily activity and anxiety/depression.
In evaluating concurrent change in daily activity and
QOL, three studies [38,40,43] showed no change in either daily activity or QOL. One study [41] showed increased daily activity but no improvement in QOL. Another study [41] showed improvement in QOL but no
increase in daily activity. No studies found concurrent
change in daily activity and QOL.
In the assessment of concurrent change in daily activity and functional status, three studies [38,41,43] found
no change in daily activity or functional status. Two
studies [37,42] found increased daily activity without an
increase in activity participation. No study showed an
increase in daily activity and activity participation concurrently.
In comparing concurrent changes among daily activity
and exercise performance, three studies [39,41,43]
showed no change in daily activity or exercise performance. Two studies [37,42] showed increases in daily activity without associated changes in exercise performance. Two studies [38,39] demonstrated improvements in
exercise performance but no increase in daily activity.
No studies found concurrent change in daily activity and
exercise performance.

3.2. COPD
One hundred and eighty four unique articles were found
using the search strategy previously outlined. Ultimately,
nine studies [44-52] met the inclusion criteria for this
review: three randomized control trials [45,47,48], one

Figure 2. Concurrent intervention within-group effect sizes for daily activity and other
outcome measures in CHF studies.
Copyright © 2013 SciRes.
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cohort study [44], and five case control studies [44,
46,49,51,52] (Figure 3). Methodological rigor scores
ranged from 40% [51] to 90% [45]. One study [44] was
rated as “strong”, seven studies [44,46-50,52] were
judged to be “moderate”, and one study [50] was determined to be “weak”. Of these nine studies, two [47,49]
were unique to this search from the previous systematic
review and meta-analysis by Ng et al. [30]. As discussed
previously, Ng et al. [30] concluded that exercise training had little-to-no effect on physical activity in patients
with COPD. For further details regarding the results and
details of these seven included studies, refer to the full
text article by Ng et al. [30].
The two additional articles found by the present literature search reported similar conclusions. Slinde et al.
[49] explored how total daily energy expenditure
changes when underweight patients with COPD enter a
physiotherapy program. Fourteen subjects meeting the
inclusion criteria of severe COPD, as indicated by FEV1
less than 50%, and body mass-index of less than twentyone kg/m2, completed the study. In total, subjects attended eight, 90-minute physical therapy sessions consisting of moderate physical activity and an educational
intervention. The authors concluded, based on accelerometer and doubly-labeled water measurements, that the
mean total energy expenditure actually decreased 6%
during the intervention period as compared to the control,
with between-group results not statistically significant.
Probst et al. [47] compared the effect of a high intensity, whole-body endurance and strength program to a
low-intensity calisthenics-and-breathing exercise program to improve daily activity. Forty individuals with

COPD were randomized into two equal treatments groups
and completed 36 therapy sessions over a 12 week period.
Based on accelerometry, Probst et al. [47] concluded that
neither high- nor low-intensity treatment had a significant impact on improving daily energy expenditure.
Concurrent Changes between Daily Activity and
Secondary Outcomes
Figure 4 summarizes the relationship between changes
in daily activity concurrent with changes in other seconddary outcome measures by plotting the within-group effect
sizes of the intervention groups for all measures across
all nine studies. Overall, a positive linear relationship did
not exist, with the greatest changes in daily activity not
occurring concurrently with changes in other measures.
Furthermore, only one study [45] demonstrated a withingroup effect size greater than 0.50 for daily activity, with
small-to-no effects in all other outcome measures when
daily activity effect sizes where greater than 0.50.
When assessing concurrent changes in daily activity
and anxiety/depression, one study [50] showed no changes
in daily activity or anxiety/depression and another demonstrated a large effect on daily activity but no effect
on anxiety/depression [45]. Only one study [52] showed
concurrent increase in daily activity and improved anxiety/depression.
With regard to concurrent changes in daily activity
and QOL, four studies [45,47,48,50] showed no change
in either daily activity or QOL. One study [44] showed
improved QOL with no increase in daily activity. Two
studies [46,52] demonstrated concurrent change in increased daily activity and improved QOL.
In the assessment of concurrent change in daily activity and functional status, four studies [45,47,48,50] found
no change in daily activity and participation. One study
[44] showed increased functional status with no positive
effect on daily activity. Two studies [46,52] showed concurrent change in increased daily activity and improved
functional status.
In comparing concurrent changes among daily activity
and exercise performance, two studies [45,48] showed no
change in daily activity or exercise performance. One
study [52] showed increased daily activity without associated improvement in exercise performance. Three studies [44,47,50] demonstrated improvements in exercise
performance but no increase in daily activity. Only one
study [46] found a concurrent increase in daily activity
and improved exercise performance.

4. DISCUSSION
Figure 3. Search results for chronic obstructive pulmonary
disease.
Copyright © 2013 SciRes.

The purpose of the present review was to evaluate the
efficacy of exercise- and psychosocial-based intervenetions for improving daily activity in patients with COPD
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Figure 4. Concurrent intervention within-group effect sizes for daily activity
and other outcome measures in COPD studies.

and CHF. The results of the present review highlight
several important limitations of the existing literature.
More importantly, however, the present review provides
insight into interventions utilized for disrupting the cycle
of inactivity and deconditioning in individuals with
COPD and CHF. Overall, the present results indicate that
exercise-based interventions play a limited role in improving daily activity, and psychosocial-based interventions are a promising, but under-investigated, intervention.
With regard to limitations of the existing literature on
interventions for improving daily activity in individuals
with COPD and CHF, there are several noteworthy study
design and measurement deficiencies. Although there
were a greater number of studies of patients with COPD,
few utilized a randomized design compared to all six of
the studies in patients with CHF being randomized controlled trials. However, the measurement of daily activity
in the CHF literature included an objective measurement
(e.g. accelerometry) in only four studies, compared to
objective measures being used in all nine in the COPD
literature. It is therefore helpful to draw upon evidence
from both populations when evaluating intervention efficacy. Indeed, similar findings were noted in both, with
exercise-based interventions having little effect on daily
activity.
With regard to the role of either exercise- and/or psychosocial-based interventions for disrupting the cycle of
inactivity and deconditioning, psychosocial interventions
appeared to have the greatest efficacy. Only four of nine
studies [45,46,48,52] in patients with COPD showed
within-group improvement in daily activity, and none
demonstrated between-group changes. Similarly, two of
Copyright © 2013 SciRes.

seven studies [37,42] in patients with CHF resulted in
statistically significant effects on daily activity. However,
among the studies that demonstrated a statistically significant effect on daily activity, three of the four studies
in those with COPD [45,46,48] and both of the studies in
those with CHF [37,42] included a psychosocial component or were entirely a psychosocial-based intervention.
With regard to the cycle of inactivity and deconditioning, the results of the present study could be interpreted in two ways: 1) inactivity and deconditioning are
not interrelated as previously proposed [8-12], or, 2) only
directing interventions towards the deconditioning component of the cycle is insufficient for making changes in
daily activity. In patients with CHF, Shoemaker et al. [53]
observed that clinically meaningful changes in 6MWT
performance were not accompanied by changes in daily
activity over time (no intervention was provided). Furthermore, as noted in the present review, changes in exercise performance in response to exercise interventions
did not occur concurrently with changes in daily activity
(e.g. studies that demonstrated improved exercise performance did not improve in daily activity and vice
versa). As previously discussed, nearly all of the studies
in both populations that included at least a psychosocial
intervention component resulted in improvements in
daily activity.
Therefore, psychosocial-based interventions for improving daily activity, although relatively under-investigated in COPD and CHF, may be a promising new intervention. It is not clear whether psychosocial-based interventions alone or in combination with exercise-based
interventions are most effective. Furthermore, it is not
known which psychosocial interventions are effective, as
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highlighted by the 2005 and 2012 studies by Witham et
al. The very low intensity, seated exercise intervention in
the 2005 study that resulted in significant improvement
in daily activity included subjects keeping “a diary of
their daily activities [that was] used as a basis for a
weekly telephone liaison [to] give encouragement and
agree on new targets for daily walking activity.” The
high intensity exercise intervention in the 2012 study that
failed to demonstrate improvement in daily activity included “guided discussion sessions based on cognitive
and behavioral techniques [that focused] on benefits of
exercise [and] goals and how to work toward them” in
addition to telephone calls every 2 weeks for the first 4
months followed by monthly phone calls for 4 months.
Thus, the key components of psychosocial support or
intervention for promoting changes in the habitual routines that impact daily activity are not clear.
Finally, the present review found that changes in QOL,
anxiety/depression, and functional status did not occur
concurrently with changes in daily activity. Although
daily activity has been shown to be associated with anxiety/depression, QOL, and functional status [18,19,24,2628,54], it is not clear why changes in these measures did
not consistently occur concurrently. No included study
investigated the effect of pharmacologic or functional
training interventions directed at improving anxiety/depression or functional status or how such interventions
might impact daily activity. It is important to note that
none of the included studies specifically accounted for
baseline depression, anxiety, or low selfefficacy as possible factors that could confound response to intervention.
In summary, based on the results of the present systematic review, it can be concluded that exercise-based
interventions alone are unable to promote an increase in
daily activity within the COPD and CHF populations.
Given the association between daily activity and other
important outcomes such as hospitalization and mortality,
clinicians should consider daily activity as clinical outcome, and should also consider the psychosocial needs of
patients as they pertain to daily activity.
Future research should focus on expanding the application of psychosocial-based interventions in subjects
with COPD and CHF. While current evidence of psychosocial-based intervention is promising, the volume of
studies is limited. Future research should also compare
the efficacy of exercise-based intervention versus psychosocial-based interventions versus a combination of
exercise and psychosocial intervention to improve daily
activity in individuals with COPD and CHF.

5. CONCLUSION
Exercise-based interventions serve a limited, if any, role
in improving daily activity in individuals with COPD
Copyright © 2013 SciRes.

and CHF. Disrupting the cycle of inactivity and deconditioning requires more than just addressing the deconditioning aspect of this cycle. Psychosocial-based interventions are a promising, but under-investigated, intervention.
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